B-lymphocyte antigen CD19

Description:

Description
  • Accession: P15391
  • Swissprot: CD19_HUMAN
  • Organism: Homo sapiens
  • Gene: CD19
  • Target class: Surface antigen

Drug Relations:

blinatumomab
a single-chain bispecific recombinant antibody from Micromet's BiTE (bispecific T-cell engager) product platform that binds both the CD19 antigen and the T-cell receptor (CD3), for the potential treatment of B-cell lymphoma Bioactivity details MOA